Needle anxiety is very common, and the good news is that GLP-1 needles are among the smallest in medicine
With the rise in the use of GLP-1s, researchers are now exploring a gut-brain-taste connection to describe the crosstalk between individual perceptions of tastes, cravings, aversions, hunger and satiety hormones, levels of nutrients in the blood, and nutrient stores in the body
All treatment plans are developed and monitored with patient safety and clinical appropriateness as primary considerations
Read our full paper here: WashU Medicine Department of Surgery #BurnCare #GeneralSurgery #GLP1 #MedicalResearch #TraumaSurgery #ClinicalInnovation #BJS #AcademicMedicine Very provocative finding
REDEFINE 1 -- CagriSema phase 3 (Aronne et al., 2025): CagriSema 2.4/2.4 mg produced 22.7% mean weight loss at 68 weeks vs 2.1% placebo